In order to verify first-hand cannabis crops and the practices that must be implemented by the companies licensed to grow cannabis for medical purposes, the Minister of Justice and Law, Margarita Cabello Blanco, visited the facilities of the company PharmaCielo Colombia Holding. The senior official verified the protocols and confirmed the company’s compliance with the requirements.
Margarita Cabello Blanco, Minister of Justice and Law, described the meeting as a positive strategy of articulation and coordination between state entities involved in the regulation of the cannabis industry.
Hemp.im mobile application delivers hemp news in the United States and worldwide. Don’t waste time searching the internet when you can get the lastest marijuana stories in just a few touches!
Licenses for cannabis cultivation
To date, the portfolio led by Margarita Cabello Blanco has issued 607 licenses for the cultivation of medical and scientific cannabis. On the premises of the Ministry, state entities contributed their ideas to promote and consolidate pharmaceutical cannabis.
It also reviewed the issue of ‘bottlenecks’ affecting companies working with the plant in terms of planting, cannabis development, and export of authorized products. The amendments to Decree 613 of April, 10th 2017 will allow greater control and development of the cannabis industry for pharmaceutical purposes; scientific research; the linking of universities to licensed companies; and education to provide ongoing training to all stakeholders in legislation and regulation.
Importance of the cannabis industry
For his part, Dumar Cardenas, Deputy Director of Control and Enforcement of Chemicals and Narcotics of the Ministry of Justice, noted that the importance of free zones for the development of the industry in matters such as logistics and export has been discussed.
“Colombia has made progress with controls on operators to comply with the requirements of the license, especially with regard to non-psychoactive cannabis plantations,” the official added. “Colombia continues to promote the cannabis industry based on clear rules of control, quality and entrepreneurship, and with total transparency regarding the licensing process and the granting of quotas,” said Dumar Cardenas.
Visits to licensed cannabis growers
For her part, Minister Cabello explained that visits to the licensed growers will continue in order to verify on the spot compliance with the requirements demanded by the Ministry and the needs of the companies. The holder of the Justice portfolio was also able to verify the usefulness of the technical tables organized by the Ministry, which have served to improve crop development within the established regulatory framework.
The Minister of Justice often visits licensed growers who produce cannabis for medical purposes in order to verify first-hand and on-the-spot the state of the crops and the good practices to be implemented by companies licensed to grow cannabis for medical and scientific purposes.
Recently Minister Cabello Blanco visited the facilities of the company PharmaCielo Colombia Holding, located in Rionegro (Antioquia). There, she verified the protocols, inspected the cannabis crops and confirmed the compliance of the company with the requirements, always emphasizing one of the main objectives of the National Government: to promote a medical cannabis industry that is legal, safe and of high quality.
Quotas to meet legal requirements
Likewise, the Minister of Justice was able to corroborate the usefulness of the technical tables organized by the Ministry, which have served to improve the development of crops within the established regulatory framework.
Finally, the Minister highlighted the fact that the Sub-Directorate for the Control and Monitoring of Chemicals and Narcotics has issued 607 licenses to date. Together, she confirmed that by the end of the first semester of 2020 the entity will be up to date with all the applications for licenses and quotas that meet the legal requirements.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in DIARIOJURIDICO.com, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.